Quantcast
Last updated on April 24, 2014 at 0:05 EDT

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013

October 24, 2013

Reportbuyer.com just published a new market research report: Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013.

London (PRWEB) October 24, 2013

Summary

GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013" provides data on the Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Renal Failure (ARF) (Acute Kidney Injury). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

Acute Renal Failure (ARF) (Acute Kidney Injury) 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13

Top Five Countries Contributing to Clinical Trials in Europe 14

Top Countries Contributing to Clinical Trials in North America 15

Top Countries Contributing to Clinical Trials in Middle East and Africa 16

Top Five Countries Contributing to Clinical Trials in Central and South America 17

Clinical Trials by BRIC Nations 18

Clinical Trials by G7 Nations 19

Clinical Trials in G7 Nations by Trial Status 20

Clinical Trials by E7 Nations 22

Clinical Trials in E7 Nations by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Unaccomplished Trials of Acute Renal Failure (ARF) (Acute Kidney Injury) 27

Subjects Recruited Over a Period of Time 31

Prominent Sponsors 32

Top Companies Participating in Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials 34

Prominent Drug Comparison 36

Clinical Trial Profiles 37

Clinical Trial Overview of Top Companies 37

Action Pharma A/S 37

Clinical Trial Overview of Action Pharma A/S 37

AstraZeneca PLC 38

Clinical Trial Overview of AstraZeneca PLC 38

Astute Medical, Inc. 39

Clinical Trial Overview of Astute Medical, Inc. 39

AbbVie Inc. 40

Clinical Trial Overview of AbbVie Inc. 40

GlaxoSmithKline plc 41

Clinical Trial Overview of GlaxoSmithKline plc 41

Pfizer Inc. 42

Clinical Trial Overview of Pfizer Inc. 42

Quark Pharmaceuticals, Inc. 43

Clinical Trial Overview of Quark Pharmaceuticals, Inc. 43

Biosite Incorporated (Inactive) 44

Clinical Trial Overview of Biosite Incorporated (Inactive) 44

Biogen Idec Inc. 45

Clinical Trial Overview of Biogen Idec Inc. 45

Astellas Pharma Inc. 46

Clinical Trial Overview of Astellas Pharma Inc. 46

AlloCure Inc. 47

Clinical Trial Overview of AlloCure Inc. 47

Thrasos, Inc. 48

Clinical Trial Overview of Thrasos, Inc. 48

CorMedix, Inc. 49

Clinical Trial Overview of CorMedix, Inc. 49

Taiho Pharmaceutical Co., Ltd. 50

Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 50

Salix Pharmaceuticals Ltd. 51

Clinical Trial Overview of Salix Pharmaceuticals Ltd. 51

LEO Pharma A/S 52

Clinical Trial Overview of LEO Pharma A/S 52

Cephalon, Inc. 53

Clinical Trial Overview of Cephalon, Inc. 53

Novartis AG 54

Clinical Trial Overview of Novartis AG 54

Gambro Hospal S.p.A 55

Clinical Trial Overview of Gambro Hospal S.p.A 55

Randox Laboratories Ltd. 56

Clinical Trial Overview of Randox Laboratories Ltd. 56

Clinical Trial Overview of Top Institutes / Government 57

Yonsei University 57

Clinical Trial Overview of Yonsei University 57

Ghent University Hospital 58

Clinical Trial Overview of Ghent University Hospital 58

Vanderbilt University 59

Clinical Trial Overview of Vanderbilt University 59

Medical University of Vienna 60

Clinical Trial Overview of Medical University of Vienna 60

National Taiwan University Hospital 61

Clinical Trial Overview of National Taiwan University Hospital 61

University of Florida 62

Clinical Trial Overview of University of Florida 62

Austin Health 63

Clinical Trial Overview of Austin Health 63

Asan Medical Center 64

Clinical Trial Overview of Asan Medical Center 64

The University of Chicago 65

Clinical Trial Overview of The University of Chicago 65

University of Alberta 66

Clinical Trial Overview of University of Alberta 66

University of Cologne 67

Clinical Trial Overview of University of Cologne 67

Seoul National University Hospital 68

Clinical Trial Overview of Seoul National University Hospital 68

Cincinnati Children's Hospital Medical Center 69

Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 69

Hospital de Base 70

Clinical Trial Overview of Hospital de Base 70

Centre Hospitalier Universitaire de Nimes 71

Clinical Trial Overview of Centre Hospitalier Universitaire de Nimes 71

Assistance Publique – Hopitaux de Paris 72

Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 72

University of Alabama at Birmingham 73

Clinical Trial Overview of University of Alabama at Birmingham 73

University Health Network 74

Clinical Trial Overview of University Health Network 74

U.S. Department of Veterans Affairs 75

Clinical Trial Overview of U.S. Department of Veterans Affairs 75

Maine Medical Center Research Institute 76

Clinical Trial Overview of Maine Medical Center Research Institute 76

Five Key Clinical Profiles 77

Appendix 123

Abbreviations 123

Definitions 123

Research Methodology 124

Secondary Research 124

About GlobalData 125

Contact Us 125

Disclaimer 125

Source 126

1.1 List of Tables

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 11

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 12

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 13

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 14

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries, 2013* 15

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 16

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 17

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, BRIC Countries, 2013* 18

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, G7 Countries, 2013* 19

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 21

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, E7 Countries, 2013* 22

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 23

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 24

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 25

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 26

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Suspended Clinical Trials, 2013* 27

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 28

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 29

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Action Pharma A/S, 2013* 37

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 38

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astute Medical, Inc., 2013* 39

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013* 40

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 41

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 42

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Quark Pharmaceuticals, Inc., 2013* 43

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biosite Incorporated (Inactive), 2013* 44

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2013* 45

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 46

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by AlloCure Inc., 2013* 47

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Thrasos, Inc., 2013* 48

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by CorMedix, Inc., 2013* 49

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2013* 50

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals Ltd., 2013* 51

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by LEO Pharma A/S, 2013* 52

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2013* 53

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 54

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Gambro Hospal S.p.A, 2013* 55

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Randox Laboratories Ltd., 2013* 56

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2013* 57

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2013* 58

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 59

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 60

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 61

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2013* 62

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2013* 63

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2013* 64

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 65

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2013* 66

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2013* 67

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 68

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2013* 69

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Base, 2013* 70

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nimes, 2013* 71

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique – Hopitaux de Paris, 2013* 72

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 73

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2013* 74

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 75

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials Market, Global, Clinical Trials by Maine Medical Center Research Institute, 2013* 76

List of Figures

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 12

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 13

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 14

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 15

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 16

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 17

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 18

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, G7 Countries (%), 2013* 19

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 20

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, E7 Countries (%), 2013* 22

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 23

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 24

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 25

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 26

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 31

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34

Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 36

GlobalData Methodology 124

Read the full report:

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/diseases/acute_renal_failure_arf_acute_kidney_injury_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11266072.htm


Source: prweb